Acute Kidney Injury and Ultra-endurance Running

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-50
SponsorArizona State University

About this trial

This study aims to understand how participating in the Western States Endurance Run (WSER), a 100-mile ultramarathon, affects kidney health. Long, strenuous exercise in hot conditions can temporarily strain the kidneys, especially when combined with dehydration, muscle breakdown, and the use of common pain-relief medications such as ibuprofen. Although kidney stress has been reported in endurance sports, no study has examined it directly in runners during the WSER using newer, more sensitive urine markers of kidney injury. Runners who volunteer will complete brief assessments before and after the race. These include providing a urine sample, a small finger-prick blood sample, a body-weight measurement, and answering a short questionnaire about pain-medication use. During the race, participants will wear a global positioning system (GPS) watch and heart-rate strap to monitor effort. Each assessment takes about 15 minutes, and no follow-up is required. Findings from this study will help determine how often kidney stress occurs in this event and what factors may contribute to it, ultimately supporting safer training and medical practices for ultramarathon athletes.

Eligibility criteria

Qualifiers

Running in the Western States Endurance Run in either 2026, 2027 or 2028

No contraindications to exercise as indicated by the Physical Activity Readiness Questionnaire (PAR-Q+) as prepared by the American College of Sports Medicine (ACSM)

Not currently taking medicine or experiencing illness that may influence the cardiovascular or neuromuscular system

Age ≥18 and ≤ 50 years old and injury free (skeletal muscle) for > 3 months

Disqualifiers

Minors (under 18)

Adults who are unable to consent (impaired decision-making capacity)

Prisoners

Pregnant Women

Trial design

Treatments tested in this trial

  • Sodium Bicarbonate (NaHCO3)
  • Placebo

Treatment groups

30 Participants
are divided into 2 treatment groups

Locations

This trial has no locations

Sponsors and collaborators

Arizona State University

Lead sponsor

Western States Endurance Run Research Foundation

Collaborator